tiprankstipranks
NeueHealth Inc (NEUE)
NYSE:NEUE
US Market

NeueHealth Inc (NEUE) Income Statement

172 Followers

NeueHealth Inc Income Statement

Last quarter (Q3 2023), NeueHealth Inc's total revenue was $269.40M, a decrease of -83.50% from the same quarter last year. In Q3, NeueHealth Inc's net income was $-646.36M. See NeueHealth Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ -1.74B$ 2.41B$ 3.90B$ 1.20B$ 272.32M
Cost of Revenue
---$ 1.05B$ 224.39M
Gross Profit
---$ 151.55M$ 47.94M
Operating Expense
---$ 417.62M$ 181.62M
Operating Income
$ 713.38M$ -622.25M$ -1.21B$ -266.07M$ -133.69M
Net Non Operating Interest Income Expense
---$ 0.00-
Other Income Expense
$ -336.46M$ -654.87M$ -1.23M$ 8.47M$ 8.35M
Pretax Income
$ -559.68M$ -634.28M$ -1.20B$ -257.60M$ -125.34M
Tax Provision
$ -5.78M$ 3.68M$ -26.52M$ -9.16M$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ 1.94B$ -1.50B$ -1.18B$ -248.44M$ -125.34M
Basic EPS
$ -96.87$ -2.38$ -6.04$ -0.40$ -0.20
Diluted EPS
$ -99.41$ -2.38-$ -0.40$ -0.20
Basic Average Shares
$ 1.28B$ 629.46M$ 392.24M$ 615.37M$ 615.37M
Diluted Average Shares
$ 1.28B$ 629.46M$ 392.24M$ 615.37M$ 615.37M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ -4.58B$ -3.03B$ 5.23B$ 1.46B$ 406.01M
Net Income From Continuing And Discontinued Operation
$ 1.13B$ -1.50B$ -1.18B$ -248.44M$ -125.34M
Normalized Income
$ -111.60M$ -1.01B-$ -256.61M$ -133.69M
Interest Expense
$ 20.61M$ 12.82M$ -7.96M$ 0.00-
EBIT
$ -44.41M-$ -1.20B$ -266.07M$ -133.69M
EBITDA
$ -24.52M-$ -1.17B$ -257.78M$ -132.55M
Currency in USD

NeueHealth Inc Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis